DEF 14ABJDXCIK 0001704287

Bluejay Diagnostics, Inc.

Name: SEC EDGAR filing 0001213900-25-044931
Creator: Bluejay Diagnostics, Inc.
License: https://www.usa.gov/government-works

Proxy statement (DEF 14A) filed May 16, 2025.

Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.

Read the filing on SEC.gov All documents in this filing

New to the DEF 14A? What it is and how to read one

Filing facts

Accession number: 0001213900-25-044931
Filer: Bluejay Diagnostics, Inc.
Ticker: BJDX
CIK: 0001704287
Form type: DEF 14A
Form description: Proxy statement
Filed at: May 16, 2025
Period of report: June 18, 2025
Industry: SIC 3841Surgical & Medical Instruments
Filing size: 6.7 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Bluejay Diagnostics, Inc.

See all 43 filings from Bluejay Diagnostics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1704287/000121390025044931/0001213900-25-044931-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Bluejay Diagnostics, Inc. (0001704287) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.